RonaldLeoPaquetteMD

Professor, Medicine, UCLA School of Medicine

Dr. Paquette is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
8700 Beverly Blvd.
AC1070
Los Angeles, CA 90095
Phone+1 310-423-1160

Fax+1 310-659-8045

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1990
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1984 - 1987
Ohio State University College of MedicineClass of 1984

PubMed

Low booster uptake in cancer patients despite health benefits.
Jane C Figueiredo, Julia Levy, So Yung Choi, Alexander M Xu, Noah M Merin
Iscience. 2024-09-20
1 citations
Successful autologous hematopoietic stem cell transplants using Salmonella positive products collected from asymptomatic donors.
Samantha Phou, Ingrid Perez-Alvarez, Margie Morgan, Deisy A Contreras, Michael Ben-Aderet
Transfusion. 2023-04-01
33 citations
Longitudinal SARS-CoV-2 mRNA vaccine-induced humoral immune responses in cancer patients.
Jane C. Figueiredo, Noah Merin, Omid Hamid, So Yung Choi, Tucker Lemos
Cancer Research. 2021-11-10

Abstracts/Posters

Phase 1 Dose Escalation and Expansion Study to Determine Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the BET Inhibitor FT-1101 As a Single Agent in...
Ronald Paquette, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Cedars-Sinai’s Stem Cell and Bone Marrow Transplant Program Recognized with Two Major Hallmarks of QualityJanuary 18th, 2023
Hitting Stem Cell and CAR T TargetsJanuary 17th, 2023
Blood & Marrow Transplant Outcomes Exceed ExpectationsJanuary 18th, 2022

Phase I Study Of Recombinant Human Hemoglobin (Rhb1.1) In Patients W/AnemiaNational Center For Research Resources1999–2001
Phase I/II Trial Of Recombinant Methionyl Human Stem Cell FactorNational Center For Research Resources1995–1999
Phase I Study Of Recombinant Human Hemoglobin (Rhb1.1) In Patients W/Anemia ASSNational Center For Research Resources1998
Myeloid Specific Regulation Of IGG FC Receptor Type INational Heart, Lung, And Blood Institute1994–1997
Myeloid-Specific Regulation Of IGG FC Receptor Type INational Heart, Lung, And Blood Institute1993